Evidence map›Paper›PMID 30659273›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2019

Unlocking bone for proteomic analysis and FISH.

Claudius Mueller, Marco Gambarotti, Stefania Benini, Piero Picci, Alberto Righi, Monica Stevanin, Sabine Hombach-Klonisch, Dana Henderson, Lance Liotta, Virginia Espina

Abstract read
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Laser capture microdissection.Nature reviews. Methods primers · 2025
    Article
  3. Article
  4. Article
  5. Tissue Morphology and Antigenicity in Mouse and Rat Tibia: Comparing 12 Different Decalcification Conditions.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2019
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Claudius MuellerCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA.ORCID 0000-0003-4499-4724
Marco GambarottiDepartment of Pathology, IRCCS, Istituto Ortopedico Rizzoli, Bologna, Italy.
Stefania BeniniDepartment of Pathology, IRCCS, Istituto Ortopedico Rizzoli, Bologna, Italy.
Piero PicciDepartment of Pathology, IRCCS, Istituto Ortopedico Rizzoli, Bologna, Italy.
Alberto RighiDepartment of Pathology, IRCCS, Istituto Ortopedico Rizzoli, Bologna, Italy.ORCID 0000-0002-1074-0155
Monica StevaninDepartment of Pathology, IRCCS, Istituto Ortopedico Rizzoli, Bologna, Italy.
Sabine Hombach-KlonischDepartment of Human Anatomy and Cell Science, Rady Faculty of Health Sciences, University of Manitoba, Manitoba, Winnipeg, Canada.
Dana HendersonDepartment of Human Anatomy and Cell Science, Rady Faculty of Health Sciences, University of Manitoba, Manitoba, Winnipeg, Canada.
Lance LiottaCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA. lliotta@gmu.edu.
Virginia EspinaCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA.

Funding

Implementation of phosphoprotein preservation technology for cancer biospecimensR33CA157403 · NCI · GEORGE MASON UNIVERSITY · PI LIOTTA, LANCE ALLEN · 2011 to 2013
$922k
Surrogate and Sentinal Technologies to Monitor Stability of Cancer PhosphoproteinR21CA125698 · NCI · GEORGE MASON UNIVERSITY · PI LIOTTA, LANCE ALLEN · 2008 to 2009
$330k
NCI NIH HHS R21 CA125698NCI NIH HHS R33 CA157403
6 · The paper itself

Abstract

Bone tissue is critically lagging behind soft tissues and biofluids in our effort to advance precision medicine. The main challenges have been accessibility and the requirement for deleterious decalcification processes that impact the fidelity of diagnostic histomorphology and hinder downstream analyses such as fluorescence in-situ hybridization (FISH). We have developed an alternative fixation chemistry that simultaneously fixes and decalcifies bone tissue. We compared tissue morphology, immunohistochemistry (IHC), cell signal phosphoprotein analysis, and FISH in 50 patient matched primary bone cancer cases that were either formalin fixed and decalcified, or theralin fixed with and without decalcification. Use of theralin improved tissue histomorphology, whereas overall IHC was comparable to formalin fixed, decalcified samples. Theralin-fixed samples showed a significant increase in protein and DNA extractability, supporting technologies such as laser-capture microdissection and reverse phase protein microarrays. Formalin-fixed bone samples suffered from a fixation artifact where protein quantification of β-actin directly correlated with fixation time. Theralin-fixed samples were not affected by this artifact. Moreover, theralin fixation enabled standard FISH staining in bone cancer samples, whereas no FISH staining was observed in formalin-fixed samples. We conclude that the use of theralin fixation unlocks the molecular archive within bone tissue allowing bone to enter the standard tissue analysis pipeline. This will have significant implications for bone cancer patients, in whom personalized medicine has yet to be implemented.

Indexed as

Gene ExpressionAnimalsBone and BonesBone NeoplasmsFixativesFormaldehydeHumansImmunohistochemistryIn Situ Hybridization, FluorescenceMice, Inbred BALB CMice, Inbred ICRProteomeProteomicsReproducibility of ResultsTissue FixationFixativesFormaldehydeProteome

Identifiers

PMID30659273
PMCPMC10752433

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.